BRCA1 and neoplasm: Aside from enrichment of breakpoints in genes and exons, we also wanted to test whether there are larger regions of the genome, including non-coding regions, that are enriched for indel or SV breakpoints in our set of 46 BRCA1/2-mutated tumor samples.